AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. "As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines," the Anglo-Swedish pharmaceutical company said.

Australia Vaccines Company Covid Available Vaccine Astrazeneca Vaxzevria Tss  vaccines  covid19  decline  available  withdraws  tss  vaccine  health  astrazeneca  blood  australia  demand  vaxzevria  citing  company

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
8 months ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
8 months ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
8 months ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
8 months ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

Stopped manufacturing Covishield since December 2021, says Serum Institute
8 months ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021
8 months ago

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021

New Indian Express  

NEW DELHI: Days after AstraZeneca admitted for the first time in court documents that their Covid-19 vaccine can cause a rare and dangerous side effect, the British pharma giant announced that they are withdrawing it globally. In its statement, AstraZeneca said, "As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. According to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year
1 year, 11 months ago

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. A year earlier the business sold 1.8 billion US …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 3 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

CDC endorses more traditional Novavax COVID-19 shot
2 years, 5 months ago

CDC endorses more traditional Novavax COVID-19 shot

LA Times  

A dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use. U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the body to fight the …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative

LA Times  

A worker moves boxes carrying Novavax’s COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9. Novavax, the company behind a COVID-19 vaccine touted as a key tool for the developing world, will miss a target for giving doses to a U.N.-backed effort to supply shots to poorer countries. The company behind a COVID-19 vaccine touted as …

Rich Countries Getting New COVID Vaccine Before Poorer Ones
2 years, 9 months ago

Rich Countries Getting New COVID Vaccine Before Poorer Ones

Huff Post  

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. via Associated Press NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Poorer nations reject over 100 million Covid shots as many close to expiry
2 years, 11 months ago

Poorer nations reject over 100 million Covid shots as many close to expiry

India Today  

Poorer nations last month rejected more than 100 million doses of Covid-19 vaccines distributed by the global programme COVAX, mainly due to their rapid expiry date, a UNICEF official said on Thursday. UNICEF's data on supplies and use of delivered vaccines show that 681 million shipped doses are currently stored in about 90 poorer nations, according to CARE, a charity, …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

EU approves 5th COVID-19 vaccine, by Novavax
3 years ago

EU approves 5th COVID-19 vaccine, by Novavax

LA Times  

The EU’s drug regulator, European Medicines Agency in Amsterdam, concluded that the vaccine is safe and effective. The European Union’s executive branch on Monday authorized a fifth COVID-19 vaccine for use in the 27-nation bloc, giving the green light to the two-dose vaccine made by U.S. biotech company Novavax. “At a time where the Omicron variant is rapidly spreading, and …

India’s Serum Institute resumes vaccine exports to COVAX
3 years, 1 month ago

India’s Serum Institute resumes vaccine exports to COVAX

Al Jazeera  

The world’s largest vaccine maker halted shipments of COVID shots in March as India saw an explosion in infections. The Serum Institute of India, the world’s largest vaccine maker, has resumed exports of coronavirus vaccines to the UN-backed COVAX distribution programme after halting most overseas sales in March. At the time, Serum Institute had contracts to provide COVAX with 200 …

Coronavirus updates | Moderna lowers forecast for 2021 COVID-19 vaccine deliveries
3 years, 2 months ago

Coronavirus updates | Moderna lowers forecast for 2021 COVID-19 vaccine deliveries

The Hindu  

With 12,885 people testing positive for coronavirus in a day, India's total tally of COVID-19 cases rose to 3,43,21,025, while the active cases were recorded at 1,48,579, according to the Union Health Ministry data updated on Thursday. Here are the latest updates : South Korea South Korea buys 30 million doses of Pfizer's COVID-19 vaccine for 2022 South Korea on …

Australia plans to stop AstraZeneca vaccine production — but how will it affect our neighbours?
3 years, 2 months ago

Australia plans to stop AstraZeneca vaccine production — but how will it affect our neighbours?

ABC  

The federal opposition and aid groups are urging the government to extend its contract with biotech giant CSL to manufacture more AstraZeneca vaccines in Melbourne, saying Australia should ramp up production next year to help vanquish the COVID-19 pandemic. Key points: Around 12.5 million AstraZeneca doses have been administered to Australians, while more than 3.5 million doses have been sent …

CureVac stops Covid-19 vaccine development; Netherlands was to receive 10.7 million doses
3 years, 2 months ago

CureVac stops Covid-19 vaccine development; Netherlands was to receive 10.7 million doses

NL Times  

German company CureVac announced on Tuesday that it stopped the development of its vaccine against Covid-19, the respiratory disease caused by the novel coronavirus. The Netherlands ordered some 10.7 million doses of this vaccine as part of its vaccination strategy. CureVac now withdrew its vaccine, CVnCoV, from regulatory review and terminated its agreement with the European Commission to buy 405 …

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment
3 years, 3 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 3 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorize COVID antibody treatment
3 years, 3 months ago

AstraZeneca asks FDA to authorize COVID antibody treatment

LA Times  

AstraZeneca has asked the Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The Anglo-Swedish company said Tuesday that the …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 3 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

Covax misses its 2021 delivery target — what’s gone wrong in the fight against vaccine nationalism?
3 years, 3 months ago

Covax misses its 2021 delivery target — what’s gone wrong in the fight against vaccine nationalism?

The Hindu  

The latest supply forecast for Covax — the programme for sharing COVID-19 vaccines around the world — suggests that accelerating vaccination in low-income countries looks unlikely. Covax estimates it will have distributed 1.425 billion vaccine doses by the end of 2021, significantly less than the 2 billion doses it was aiming for earlier this year. Only 280.5 million COVID-19 vaccine …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 4 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting
3 years, 4 months ago

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting

ABC  

The nation's peak medical body has issued a stark warning: if you're over 60 and are hoping to get the Pfizer COVID-19 jab, you could die waiting. Key points: More than half a million Australians aged between 60 and 69 haven't received a single COVID-19 vaccine dose The Prime Minister has penned a letter urging Australians over 60 to get …

Leftover AstraZeneca vaccines discarded despite hopes they will be donated
3 years, 4 months ago

Leftover AstraZeneca vaccines discarded despite hopes they will be donated

NL Times  

Tens of thousands of leftover AstraZeneca Covid-19 vaccines will soon end up in the trash. “You are not sure if the vaccines were always stored at the right temperature and if they still work optimally”, the spokesperson of the Ministry of Health said. AstraZeneca vaccines must be stored at between two to eight degrees Celsius, otherwise, they become less effective. …

Pfizer COVID-19 jab declines faster than AstraZeneca: study
3 years, 4 months ago

Pfizer COVID-19 jab declines faster than AstraZeneca: study

The Hindu  

The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. It found that "the dynamics of immunity following …

COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 4 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. …

Pfizer, AstraZeneca Covid vaccines less effective against Delta variant: Study
3 years, 4 months ago

Pfizer, AstraZeneca Covid vaccines less effective against Delta variant: Study

Deccan Chronicle  

London: The COVID-19 vaccines by Pfizer and AstraZeneca are less effective against the Delta variant of coronavirus compared to the Alpha variant, according to a study led by researchers at the University of Oxford. However, Delta infections after two vaccine doses had similar peak levels of virus as those in unvaccinated people, the researchers said. Two doses of Pfizer-BioNTech have …

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available
3 years, 4 months ago

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available

ABC  

Young Australians in locked-down cities are rolling up their sleeves in massive numbers to protect themselves with the AstraZeneca vaccine. Unvaccinated younger workers who cannot work from home are continuing to circulate the virus in Sydney, and the NSW government is hoping higher vaccination rates will put downward pressure on the infection curve, as well as reduce the number of …

The Latest: Israel sees high demand for 3rd vaccine shots
3 years, 5 months ago

The Latest: Israel sees high demand for 3rd vaccine shots

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. An age-old human gesture now in limbo — Once …

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta
3 years, 5 months ago

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta

ABC  

Back in April, the Prime Minister stood up at a late-night press conference and announced the Pfizer vaccine would be preferred over AstraZeneca for most people under 50. Key points: Two doses of AstraZeneca is 92 per cent effective against hospitalisation from the Delta variant, a UK study found Two doses of AstraZeneca is 92 per cent effective against hospitalisation …

FDA is letting troubled COVID vaccine factory restart, company says
3 years, 5 months ago

FDA is letting troubled COVID vaccine factory restart, company says

LA Times  

A vial of Johnson & Johnson’s COVID-19 vaccine is used at a pop-up clinic in the Staten Island. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The lapses at the Bayview factory have hampered J&J’s efforts to be a major player in …

Hundreds of unused AstraZeneca doses in NT could be used in Timor-Leste, WHO doctor says
3 years, 5 months ago

Hundreds of unused AstraZeneca doses in NT could be used in Timor-Leste, WHO doctor says

ABC  

Hundreds of unused AstraZeneca doses provided to the Northern Territory's Aboriginal health services are due to expire soon after Pfizer became the preferred vaccine for the remote rollout. Key points: Hundreds of AstraZeneca vaccines in the NT need to be redistributed A WHO expert says Australia's AstraZeneca supplies are critical to the rollout in Timor-Leste Australia has committed to giving …

Thousands of AstraZeneca vaccines may be thrown away
3 years, 5 months ago

Thousands of AstraZeneca vaccines may be thrown away

Dutch News  

Tens of thousands of doses of the AstraZeneca vaccine, currently in storage at family doctors’ surgeries, are likely to end up being thrown away after all, the Volkskrant reported on Wednesday. ‘The law states that medicines which have been delivered to doctors for their patients cannot be traded in, even if they are free and for a good cause,’ a …

Thousands of AstraZeneca vaccines may be thrown away
3 years, 5 months ago

Thousands of AstraZeneca vaccines may be thrown away

Dutch News  

Tens of thousands of doses of the AstraZeneca vaccine, currently in storage at family doctors’ surgeries, are likely to end up being thrown away after all, the Volkskrant reported on Wednesday. ‘The law states that medicines which have been delivered to doctors for their patients cannot be traded in, even if they are free and for a good cause,’ a …

Discover Related